Aakash Desai: Real-World Data on Immunotherapy Use in Early NSCLC

Aakash Desai Associate Director of Phase 1 and Precision Oncology Program at UAB O’Neal Comprehensive Cancer Center shared a post on LinkedIn:

“Real-World Data on Immunotherapy Use in Early NSCLC.

Pleased to share the real-world data on immunotherapy use in early-stage NSCLC presented by our team UAB O’Neal Comprehensive Cancer Center and collaborators at Flatiron Health at ХWCLC24!

Key findings:

• Real-world insights on distant metastasis-free survival in early NSCLC patients
• Analysis of metastasis sites and the need for improved biomarker testing highlighted

Exciting work that underscores the importance of translating clinical research into everyday practice.”

Source: Aakash Desai/LinkedIn